Luca Giulio Cossa Selected Research

platinum(II) 2,4-pentanedionate

1/2014

[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Giulio Cossa Research Topics

Disease

4	Neoplasms (Cancer) 01/2019 - 11/2014
3	Malignant Mesothelioma 01/2019 - 01/2016
2	Breast Neoplasms (Breast Cancer) 11/2014 - 01/2014
1	Inflammation (Inflammations) 01/2020
1	Glioma (Gliomas) 01/2020
1	Pain (Aches) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Mesothelioma 11/2015
1	Neuroblastoma 01/2014

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 11/2014
2	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 01/2014
1	Extracellular Matrix ProteinsIBA 01/2020
1	BradykininIBA 01/2020
1	ProstaglandinsIBA 01/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2019
1	EnzymesIBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	CaspasesIBA 01/2019
1	Adenosine Diphosphate (ADP)IBA 11/2018
1	Protein Isoforms (Isoforms)IBA 11/2015
1	PlatinumIBA 11/2014
1	acetyl acetonate (acetylacetonate)IBA 11/2014
1	dimethyl sulfideIBA 11/2014
1	Metalloproteases (Metalloproteinases)IBA 01/2014
1	platinum(II) 2,4-pentanedionateIBA 01/2014

Therapy/Procedure

2	Therapeutics 01/2019 - 11/2015
1	Drug Therapy (Chemotherapy) 01/2016